Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

Cited by (104)

Items 101–104 of 104

1. Apolipoprotein E Proteinopathy Is a Major Dementia-Associated Pathologic Biomarker in Individuals with or without the APOE Epsilon 4 Allele
   Gal, Jozsef, Katsumata, Yuriko, Zhu, Haining, Srinivasan, Sukanya, Chen, Jing, Johnson, Lance Allen, Wang, Wang-Xia, Golden, Lesley Renee, Wilcock, Donna M., Jicha, Gregory A. et al. · 2022 · The American Journal of Pathology
2. Somatic cancer variants enriched in Alzheimer’s disease microglia-like cells drive inflammatory and proliferative states
   Huang, August Yue, Zhou, Zinan, Talukdar, Maya, Enyenihi, Liz, Miller, Michael B., Chhouk, Brian, Rosen, Ila, Zheng, Mengyue, Zhou, Minye, Yang, Averill et al. · 2026 · Cell
3. Fatty acid-based lipidomics and membrane remodeling induced by apoE3 and apoE4 in human neuroblastoma cells
   Prasinou, Paraskevi, Dafnis, Ioannis, Giacometti, Giorgia, Ferreri, Carla, Chroni, Angeliki, Chatgilialoglu, Chryssostomos · 2017 · Biochimica et Biophysica Acta (BBA) - Biomembranes
4. The Emerging Role of PCSK9 in the Pathogenesis of Alzheimer’s Disease: A Possible Target for the Disease Treatment
   Testa, Gabriella, Giannelli, Serena, Staurenghi, Erica, Cecci, Rebecca, Floro, Lucrezia, Gamba, Paola, Sottero, Barbara, Leonarduzzi, Gabriella · 2024 · International Journal of Molecular Sciences